Product Information
TERAZOSIN 2 MG CAPSULE is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.1055 per EA under NDC 59746038406. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 20, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746038406
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TERAZOSIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075317FDA Approved
12/20/2004
TE Code
AB
On Market Since
12/20/2004
Pharmacological Classes
Price Statistics
The NADAC for TERAZOSIN 2 MG CAPSULE has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 76.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1055 per EA |
|---|---|
| All-time high | $0.1648 (Oct 14, 2020) |
| All-time low | $0.0579 (Aug 19, 2015) |
| 52-week high | $0.1210 |
| 52-week low | $0.1029 |
| Median price | $0.1316 |
| Average price | $0.1154 |
| Largest weekly change | +46.4% (Jan 17, 2018) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 40% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Jubilant Cadista Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Terazosin Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TERAZOSIN 2 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TERAZOSIN 2 MG CAPSULE, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.1055 per EA (NDC 59746038406), effective Sep 30, 2026.
How has the price of TERAZOSIN 2 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TERAZOSIN 2 MG CAPSULE has risen 76.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TERAZOSIN 2 MG CAPSULE?
Since Nov 28, 2013, the NADAC for TERAZOSIN 2 MG CAPSULE has ranged from a low of $0.0579 (Aug 19, 2015) to a high of $0.1648 (Oct 14, 2020), with a median of $0.1316 per EA.
Are there cheaper alternatives to TERAZOSIN 2 MG CAPSULE?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TERAZOSIN 2 MG CAPSULE, is $0.0638 per EA — about 40% below TERAZOSIN 2 MG CAPSULE.
Who manufactures TERAZOSIN 2 MG CAPSULE?
TERAZOSIN 2 MG CAPSULE (NDC 59746038406) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.